Pandion Therapeutics competitorsClear all

Pandion Therapeutics's top competitors include ImCheck Therapeutics, Kymera Therapeutics, Rubius Therapeutics and Atara Biotherapeutics.

Save Comparison	Pandion Therapeutics Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.	ImCheck Therapeutics ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .	Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.	Rubius Therapeutics Rubius is developing a new class of drugs, Red-Cell Therapeutics™.	Atara Biotherapeutics Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.
Founding Date	Founding Date 2017	Founding Date 2015	Founding Date 2017	Founding Date 2013	Founding Date 2012
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy
Locations	Locations Cambridge, US HQ Watertown, US	Locations Marseille, FR HQ	Locations Watertown, US HQ	Locations Cambridge, US HQ Smithfield, US	Locations South San Francisco, US HQ Zug, CH Aurora, US New York, US Thousand Oaks, US
Employees	Employees 63	Employees 403% increase	Employees 8010% increase	Employees 17423% increase	Employees 39326% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 842.7 m	Valuation ($) 1.4 b
Twitter followers	Twitter followers 250	Twitter followers 423	Twitter followers 1.8 k	Twitter followers 1.1 k	Twitter followers 1.3 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) 6	Number of tweets (last 30 days) 7	Number of tweets (last 30 days) 12	Number of tweets (last 30 days) 22	Number of tweets (last 30 days) 19
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 4.7	Average likes per tweet (last 30 days) 5	Average likes per tweet (last 30 days) 7.7	Average likes per tweet (last 30 days) 3	Average likes per tweet (last 30 days) 10.6
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%
Alexa Website Rank	Alexa Website Rank 291875	Alexa Website Rank N/A	Alexa Website Rank 336012	Alexa Website Rank 339837	Alexa Website Rank 238554
Financial
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ($167.7m) (FY, 2020)	Net income ($291m) (FY, 2019)
Funding
Latest funding round	Latest funding round $ 80m (11 months ago)	Latest funding round $ 53.2m (about 1 year ago)	Latest funding round $ 102m (12 months ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 138m	Total funding raised $ 76.1m	Total funding raised $ 197m	Total funding raised $ 245m	Total funding raised $ 61.8m